RT MartyParty (@martypartymusic)New @solana DAT: Sharps Technology, Inc. Announces Over $400 Million Private Placement Seeking to Establish the Largest Solana Digital Asset Treasury StrategyNew York – August 25, 2025 – Sharps Technology, Inc. (the “Company” or “Sharps Technology”) (NASDAQ: “STSS” and “STSSW”) today announced the pricing of a private placement offering to support its plans to adopt a digital asset treasury strategy under which the principal holding will be SOL, the native digital asset of th ...

Core Viewpoint - Cosmos Health Inc. has initiated the purchase of Ethereum (ETH) as part of its digital asset treasury reserve strategy, marking a significant step towards integrating cryptocurrency into its financial strategy [1][2]. Group 1: Company Strategy - The company has completed an initial purchase of $1 million in ETH, utilizing a financing facility of up to $300 million with a U.S.-based institutional investor [1]. - CEO Greg Siokas expressed enthusiasm about building an ETH treasury, indicating a shift from holding only cash to incorporating assets with strong appreciation potential [2]. - The strategic move is supported by the growing adoption of ETH by institutional investors, its inclusion in ETFs, and the proposed expansion of cryptocurrency access in retirement plans [2]. Group 2: Company Overview - Cosmos Health Inc. is a diversified, vertically integrated global healthcare group, incorporated in 2009 in Nevada [3]. - The company owns a portfolio of proprietary pharmaceutical and nutraceutical brands and operates under European Good Manufacturing Practices (GMP) [3]. - Cosmos Health is expanding its global distribution platform and has established R&D partnerships targeting major health disorders, enhanced by AI drug repurposing technologies [3].

Core Insights - Artelo Biosciences, Inc. has entered into a securities purchase agreement for a PIPE, raising approximately $9.475 million through the sale of 906,687 shares of common stock and associated warrants [1][5] - The company plans to utilize the proceeds to launch a Solana-centric digital asset treasury strategy, marking it as the first publicly traded pharmaceutical company to adopt Solana's native cryptocurrency, SOL, as a reserve asset [2][13] - Bartosz Lipiński, a key figure in the Solana ecosystem, will serve as a technical partner for Artelo's treasury initiative, emphasizing the strategic importance of this move for the company's growth [3][4] Financial Strategy - The funds raised will support Artelo's ongoing business and its innovative treasury initiative, which aims to diversify its balance sheet and enhance liquidity management [2][5] - The treasury strategy is designed to preserve working capital for the continued development of Artelo's proprietary therapeutics while providing exposure to a next-generation monetary network [13] Market Positioning - Artelo's adoption of SOL positions the company at the intersection of biotechnology and decentralized finance, showcasing its commitment to forward-thinking financial management [2][4] - The integration of SOL into Artelo's treasury strategy is expected to enhance shareholder value and demonstrate leadership in the evolving capital landscape of the biotech sector [5][13] Solana Overview - Solana, launched in 2020, is recognized for its high-performance blockchain capabilities, processing over 35.99 million daily transactions and boasting a Total Value Locked (TVL) of $89.417 billion, surpassing Ethereum [11][10] - The network's scalability and decentralized infrastructure are highlighted as key advantages, making it a cornerstone of the future financial ecosystem [4][10]

Core Insights - Eyenovia, Inc. is advancing its digital asset capital strategy by building a strategic treasury of HYPE, the native token of the Hyperliquid protocol [1][7] - Avenue Capital Group has become the largest common stockholder and has amended Eyenovia's senior secured debt to support the HYPE treasury, extending the maturity date to July 1, 2028, and reducing the interest rate from 12% to 8% [2] - Max Fiege has been appointed as Strategic Advisor to enhance the HYPE Treasury strategy, focusing on stakeholder education and ecosystem advocacy [4] Financial Developments - The amendment to the debt includes interest-only payments for the first 18 months, followed by equal principal and interest payments for the next 18 months [2] - The reduced interest rate and extended maturity are expected to provide financial flexibility as the company builds its HYPE treasury [2] Strategic Appointments - Max Fiege, with a background in blockchain and digital assets, will assist in the treasury architecture and risk oversight for Eyenovia [4][5] - His expertise is anticipated to enhance the company's position in the digital finance landscape [5] HYPE Token Overview - HYPE is the native token of the Hyperliquid layer one blockchain, allowing for non-custodial trading and offering utility such as trading fee discounts [6] - As of June 2025, HYPE ranks as the 12th-largest cryptocurrency by market capitalization [6] Company Overview - Eyenovia is a pioneering digital ophthalmic technology company, focusing on both innovative eye treatment solutions and building a treasury of HYPE [7] - The company is also developing the Optejet User Filled Device, targeting multiple billion-dollar markets in ophthalmic treatments [8]

Core Viewpoint - DeFi Development Corp. has made a strategic investment in Solana, acquiring 20,473 SOL for approximately $2.97 million, bringing its total holdings to 420,690 SOL valued at around $61.9 million, including staking rewards [1][2][7] Group 1: Company Strategy - The company has adopted a treasury policy focusing on Solana (SOL) as its principal holding, aiming to provide investors with access to the Solana ecosystem [3] - The recently purchased SOL will be held long-term and staked with various validators, including the company's own Solana validators, to generate native yield [2][3] Group 2: Financial Metrics - Total SOL held by the company is 420,690, valued at approximately $61.9 million [7] - The total shares outstanding are 2,011,887, resulting in a SOL per share (SPS) of 0.209 and an SPS value of $30.78 [7]

BOCA RATON, FL, April 10, 2025 (GLOBE NEWSWIRE) -- Janover Inc. (NASDAQ:JNVR) ("Janover" or the "Company") announced today the purchase of approximately $4.6 million Solana (SOL) — the first execution under its newly adopted digital asset treasury strategy. The Company will begin staking its SOL position immediately, generating revenue while supporting the Solana network. This marks the first allocation of capital from the Company's recently completed $42 million financing round and reflects management's co ...